Skip to main content

Biotechnology Forum

image forum biotech 24
Visuel forum biotech 25e.png

Cet événement vise à la mise en relation des élèves avec les milieux professionnels auxquels ils se destinent à travers différentes activités pendant deux jours. Soutenu par l'école, c'est un temps fort pour la filière Génie Biologique de Polytech qui a déjà formé plus de 800 ingénieurs. Un thème d'actualité dans le domaine des biotechnologies est développé à travers un programme de conférences.

Les élèves-ingénieurs organisateurs via l'association Proving Forum sont en deuxième année du cycle ingénieur. 

La 25e édition des 14 et 15 octobre 2024 qui aura lieu sur le site Polytech de Luminy aura pour thème : Océans de biotechnologies : les ressources marines pour la santé et l'environnement.

Le programme s'articulera de la manière suivante  :

  • des Conférences faisant intervenir des chercheurs et des industriels
  • des Rencontres avec des entreprises et des laboratoires de recherche
  • un Carrefour des carrières comportant des témoignages d’anciens élèves diplômés en Biotechnologies avec lesquels les élèves pourront échanger afin d'affiner leur projet professionnel. 

     

The aim of this two-day event is to put students in touch with the professional circles for which they are destined, through a variety of activities. Supported by the school, it's a highlight for Polytech's Biological Engineering program, which has already trained over 800 engineers. A topical theme in the field of biotechnology is developed through a program of conferences.

The student-engineers organizing the event, via the Proving Forum association, are in their second year of the engineering cycle. Contact them ...

The 24th edition, to be held on October 2 and 3, 2023 on the Polytech Luminy site, will be dedicated to "biotechnologies in the service of anti-cancer therapies".

The program will be structured as follows:

  • lectures by researchers and industrialists: Xavier MORELLI, Eric VIVIER, Arnaud MILLET, Frédéric BARD and Christophe GINESTIER
  • Meetings with companies and research laboratories: Imcheck Therapeutics, Innate pharma, Genoscience, D4Care - Groupe KEPAX ...
  • a Career Forum featuring testimonials from former Biotechnology graduates, with whom students can discuss and refine their career plans.

Conference themes and speakers (Program in preparation):

  • The key role of macrophages in the tumor environment and their implications in chemotherapy resistance.

    by ARNAUD MILLET, INSERM Researcher and Head of the "Mechanobiology Immunity and Cancer" team at Grenoble's Institut Advanced Biosciences (IAB), awarded the ATIP-Avenir prize in 2015 for his research.
  • Combining drugs and studying a fragment-based design approach to combat acute lymphoblastic leukemia (T-ALL)

    by XAVIER MORELLI, Research Director at the Marseille Cancer Research Center, head of the "Integrative Structural & Chemical Biology" research team. Scientific Director of the IPC Drug Discovery Platform.

  • Tumor heterogeneity in breast cancer and its influence on the search for new therapies

    by CHRISTOPHE GINESTIER, INSERM Researcher, head of the "Epithelial Stem Cells and Cancer" team at the Marseille Cancer Research Center, distinguished for his research by the National League Against Cancer Prize (Prix Dr. J. Almaric) in 2016.
  • Genesis of a new anti-cancer therapy and the transition from public to private sector

    by FREDERIC BARD, Director of Research at the CNRS and the Marseille Cancer Research Center, founder of "Albatroz Therapeutics".
  • Harnessing innate immunity in cancer therapy

    by ERIC VIVIER, Professor of Immunology at Aix-Marseille University and Scientific Director of Innate Pharma.

  • The contribution of circulating DNA in oncology

    by ALAIN THIERRY, Inserm Research Director at IRCM, head of the "Biomarkers for Precision Medicine in Oncology" team.